Efficacy and safety of polymyxin B in carbapenem-resistant gram-negative organisms infections.

Xia, G L; Jiang, R L

Xia, G L; Jiang, R L.

Affiliation

Xia GL; Department of Intensive Care Unit, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), Hangzhou, China.
Jiang RL; Department of Intensive Care Unit, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Traditional Chinese Medicine), NO. 54 Youdian Road, Hangzhou, 310006, China. jrl163@126.com.

BMC Infect Dis ; 21(1): 1034, 2021 Oct 04.

Article in En | MEDLINE | ID: mdl-34607561

Subject(s)

Gram-Negative Bacterial Infections; Polymyxin B; Anti-Bacterial Agents/adverse effects; Carbapenems/therapeutic use; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections/drug therapy; Humans; Microbial Sensitivity Tests; Polymyxin B/adverse effects; Retrospective Studies

Key words

Adverse reactions; Carbapenem-resistant gram-negative organisms; Infection; Polymyxin B; Rational drug use

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymyxin B / Gram-Negative Bacterial Infections Type of study: Observational_studies / Prognostic_studies Limits: Humans Language: En Journal: BMC Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2021 Document type: Article Affiliation country: China

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google